<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Good Time to Buy TEVA Stock?	</title>
	<atom:link href="https://www.wisemoneyisrael.com/good-time-to-buy-teva-stock/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.wisemoneyisrael.com/good-time-to-buy-teva-stock/</link>
	<description>Invest in Israel</description>
	<lastBuildDate>Wed, 20 Jan 2021 20:01:39 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>
		By: Israel Financial Update – April 2011 — Wise Money Israel		</title>
		<link>https://www.wisemoneyisrael.com/good-time-to-buy-teva-stock/#comment-108</link>

		<dc:creator><![CDATA[Israel Financial Update – April 2011 — Wise Money Israel]]></dc:creator>
		<pubDate>Thu, 31 Mar 2011 11:20:27 +0000</pubDate>
		<guid isPermaLink="false">https://www.wisemoneyisrael.com/?p=1558#comment-108</guid>

					<description><![CDATA[[...] Israeli pharmaceuticals giant Teva and Procter &#038; Gamble will create a new alliance in the field of over-the-counter (OTC) products. The agreement will see Procter and Gamble ally its brand-building and marketing capabilities with Teva&#8217;s experience in research, development and manufacturing in order to create a new market leader. It is expected that the collaboration will lead to the creation of new products and expand the global reach of both companies&#8217; existing offerings. The partnership should capitalize upon and further stimulate the growth of the OTC sector, which is being driven by the rising importance of health and wellness among global consumers. Teva is currently Europe&#8217;s largest generics manufacturer, while Procter and Gamble&#8217;s diverse business interests allow it to reach 4.2 billion global consumers.  You can read more about Teva here. [...]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Israeli pharmaceuticals giant Teva and Procter &amp; Gamble will create a new alliance in the field of over-the-counter (OTC) products. The agreement will see Procter and Gamble ally its brand-building and marketing capabilities with Teva&#8217;s experience in research, development and manufacturing in order to create a new market leader. It is expected that the collaboration will lead to the creation of new products and expand the global reach of both companies&#8217; existing offerings. The partnership should capitalize upon and further stimulate the growth of the OTC sector, which is being driven by the rising importance of health and wellness among global consumers. Teva is currently Europe&#8217;s largest generics manufacturer, while Procter and Gamble&#8217;s diverse business interests allow it to reach 4.2 billion global consumers.  You can read more about Teva here. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Israel Financial News Update &#8211; January 2011 — Wise Money Israel		</title>
		<link>https://www.wisemoneyisrael.com/good-time-to-buy-teva-stock/#comment-107</link>

		<dc:creator><![CDATA[Israel Financial News Update &#8211; January 2011 — Wise Money Israel]]></dc:creator>
		<pubDate>Mon, 31 Jan 2011 11:18:49 +0000</pubDate>
		<guid isPermaLink="false">https://www.wisemoneyisrael.com/?p=1558#comment-107</guid>

					<description><![CDATA[[...] Israeli flagship generic drug maker Teva Pharmaceutical rebounded off its 20-day Moving Average to gain 5% so far in January, 2011. See our article Good Time to Buy TEVA stock? [...]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Israeli flagship generic drug maker Teva Pharmaceutical rebounded off its 20-day Moving Average to gain 5% so far in January, 2011. See our article Good Time to Buy TEVA stock? [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
